Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline Q and A

被引：6

作者：

Al Sukhun, Sana ^{[1
,3
]}

Koczwara, Bogda ^{[2
]}

Temin, Sarah ^{[3
]}

Arun, Banu K. ^{[4
]}

机构：

[1] Al Hyatt Oncol Practice, Amman, Jordan

[2] Flinders Med Ctr, Bedford Pk, SA, Australia

[3] Amer Soc Clin Oncol, 2318 Mill Rd,Ste 800, Alexandria, VA 22314 USA

[4] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

来源：

JCO GLOBAL ONCOLOGY | 2024年 / 10卷

关键词：

D O I：

10.1200/GO.23.00411

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页数：8

共 12 条

[1] Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline [J].

Al Sukhun, Sana ;

Temin, Sarah ;

Barrios, Carlos H. ;

Antone, Nicoleta Zenovia ;

Guerra, Yanin Chavarri ;

Chavez-MacGregor, Mariana ;

Chopra, Rakesh ;

Danso, Michael A. ;

Gomez, Henry Leonidas ;

Homian, N'Da Marcelin ;

Kandil, Alaa ;

Kithaka, Benda ;

Koczwara, Bogda ;

Moy, Beverly ;

Nakigudde, Gertrude ;

Petracci, Fernando Enrique ;

Rugo, Hope S. ;

El Saghir, Nagi S. ;

Arun, Banu K. .

JCO GLOBAL ONCOLOGY, 2024, 10 :e2300285

[2] Breast cancer in limited-resource countries: An overview of the breast health global initiative 2005 guidelines [J].

Anderson, BO ;

Shyyan, R ;

Eniu, A ;

Smith, RA ;

Yip, CH ;

Bese, NS ;

Chow, LWC ;

Masood, S ;

Ramsey, SD ;

Carlson, RW .

BREAST JOURNAL, 2006, 12 (01) :S3-S15

[3]

[Anonymous], EEML ELECT ESSENTIAL

[4] Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline Update [J].

Burstein, Harold J. ;

Somerfield, Mark R. ;

Barton, Debra L. ;

Dorris, Ali ;

Fallowfield, Lesley J. ;

Jain, Dharamvir ;

Johnston, Stephen R. D. ;

Korde, Larissa A. ;

Litton, Jennifer K. ;

Macrae, Erin R. ;

Peterson, Lindsay L. ;

Vikas, Praveen ;

Yung, Rachel L. ;

Rugo, Hope S. .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (35) :3959-+

[5]

Gelband H., 2015, DIS CONTROL PRIORITI, V3rd, DOI 10.1596/978-1-4648-0349-9

[6] Systemic Therapy for Advanced Human 3 Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update [J].

Giordano, Sharon H. ;

Temin, Sarah ;

Chandarlapaty, Sarat ;

Crews, Jennie R. ;

Kirshner, Jeffrey J. ;

Krop, Ian E. ;

Lin, Nancy U. ;

Patt, Debra A. ;

Perlmutter, Jane ;

Ramakrishna, Naren ;

Davidson, Nancy E. ;

Franzoi, Maria Alice B. ;

Anders, Carey K. ;

Ikawa, Aki .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (23) :2612-+

[7] Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline Update [J].

Giordano, Sharon H. ;

Temin, Sarah ;

Chandarlapaty, Sarat ;

Crews, Jennie R. ;

Esteva, Francisco J. ;

Kirshner, Jeffrey J. ;

Krop, Ian E. ;

Levinson, Jennifer ;

Lin, Nancy U. ;

Modi, Shanu ;

Patt, Debra A. ;

Perlmutter, Jane ;

Ramakrishna, Naren ;

Winer, Eric P. ;

Davidson, Nancy E. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (26) :2736-+

[8]

Horton S., 2015, Cancer: disease control priorities, V3, DOI 10.1596/978-1-4648-0349-9_ch16

[9] Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update [J].

Moy, Beverly ;

Rumble, R. Bryan ;

Carey, Lisa A. .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (06) :1318-+

[10] Chemotherapy and Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Rapid Recommendation Update [J].

Moy, Beverly ;

Rumble, Bryan ;

Carey, Lisa A. .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (26) :3088-+

← 1 2 →